Article Details

ATyr Pharma Chief Scientific Officer, David King, to Resign

Retrieved on: 2018-10-16 21:30:00

Tags for this article:

Click the tags to see associated articles and topics

ATyr Pharma Chief Scientific Officer, David King, to Resign. View article details on hiswai:

Excerpt

<div>Previously it had raised five rounds of financing, including $76 million in a round led by new investor <b>Sofinnova Ventures</b> and an unnamed large ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo